It is widely held that clinical isolates of human cytomegalovirus (HCMV) are highly cell-associated, 2 and mutations affecting the UL128-131 and RL13 loci that arise in culture lead to the appearance of a cell-3 free spread phenotype. The BAC-clone Merlin (ME), expresses abundant UL128-131, is RL13-impaired and 4 produces low infectivity virions in fibroblasts, whereas TB40/e (TB) and TR are low in UL128-131, RL13-5 intact and produce virions of much higher infectivity. Despite these differences, quantification of spread by 6 flow cytometry revealed remarkably similar spread efficiencies in fibroblasts. In epithelial cells, ME spread 7 more efficiently, consistent with robust UL128-131 expression. Strikingly, ME spread far better than TB or 8 TR in the presence of neutralizing antibodies on both cell types, indicating that ME is not simply deficient at 9 cell-free spread, but is particularly efficient at cell-to-cell spread, whereas TB and TR cell-to-cell spread is 1 0 poor. Sonically disrupted ME-infected cells contained scant infectivity, suggesting that the efficient cell-to-1 1 cell spread mechanism of ME depends on features of the intact cells such as junctions or intracellular 1 2 trafficking processes. Even when UL128-131 was transcriptional repressed, cell-to-cell spread of ME was 1 3 still more efficient than TB or TR. Moreover, RL13 expression comparably reduced both cell-free and cell-to-1 4 cell spread of all three strains, suggesting that it acts at a stage of assembly and/or egress common to both 1 5 routes of spread. Thus, HCMV strains can be highly specialized for either for cell-free or cell-to-cell spread 1 6 and these phenotypes are determined by factors beyond the UL128-131 or RL13 loci. 1 7 IMPORTANCE 1 8
INTRODUCTION

7
Intervention approaches to control human cytomegalovirus (HCMV) . Adding to this complexity, some studies have shown evidence of gene inactivating 3 7 mutations (pseudogenes), and gene deletions ( 7 , 8 ) . While some infected individuals may harbor relatively 3 8 pure populations of HCMV genotypes, complex, multiple genotype infections, and sequential infections by 
Murine and guinea pig CMVs contain homologous gH/gL complexes that play similar roles in cell tropism, 5 8
although there are some differences in the reported requirements for the complexes for infection of different ( 3 8 )
. However, this did not fully explain 6 7
the observed strain differences, as TR is also low in gH/gL/UL128-131 but is congenic to ME at this locus 6 8
( 2 7 )
. Zhang et al. showed that expression of gO during replication is lower in ME-infected cells as 6 9
compared to TR, but again the genetic correlates of this difference were not clearly identified
( 3 9 )
. The cell-7 0 free infectivity of HCMV strains on both fibroblasts and epithelial cells correlates with the amounts of 7 1 gH/gL/gO in the virion envelope; TB is by far the most infectious, followed by TR, while ME virions are poorly 7 2 infectious ( 2 7 )
. Repression of the UL131 promoter in ME resulted in virions with dramatically reduced 7 3 amounts of gH/gL/UL128-131, somewhat higher levels of gH/gL/gO, and dramatically improved cell-free 7 4 infectivity ( 2 7 , 4 0 )
. 7 5
HCMV can spread through monolayer cell cultures by diffusion of cell-free virus in the culture 7 6 supernatant or by a more direct cell-to-cell mode, but the mechanistic distinctions between these types of 7 7
spread are not well characterized. Moreover, the pathway of cell-to-cell spread for HCMV has not been 7 8
extensively studied. There have been suggestions of limited fusion between infected and uninfected cells 7 9
allowing the transfer of subviral components, but the efficiency of these processes to facilitate the spread of 8 0 HCMV infection is not clear ( 4 5 -4 7 )
. Syncytium formation has been observed in HCMV infected cultures, . Different HCMV strains can be characterized as cell-free or cell-associated based on the appearance of 8 4
the foci formed in a culture monolayer. For example, ME is considered cell-associated due to formation of 8 5
tightly localized foci whereas TB forms more diffuse focal pattern characteristic of cell-free spread
Cultures of fibroblasts and epithelial cells were infected at low multiplicities and spread was 1 0 3 monitored by fluorescence microscopy over 18 days. In fibroblasts, the spread of all three strains was 1 0 4 localized to small, tight foci for the first 6 days. By day 12, TB and TR began to show signs of more diffuse 1 0 5
spread that continued to increase through day 18, whereas ME foci remained generally smaller and more 1 0 6 localized over the entire experiment ( Fig 1A) . In contrast, foci in epithelial cell cultures for all three strains 1 0 7
were smaller and more tightly localized throughout the experiment (Fig. 1B) . The more diffuse focal 1 0 8 patterns of TB and TR in fibroblasts were likely indicative of efficient cell-free spread, whereas the localized 1 0 9 spread of ME was suggestive of less efficient cell-free spread. This was consistent with our previous 1 1 0 observations that progeny virus released to culture supernatants by TB and TR were far more infectious than or rather reflect an active preference for a specialized cell-to-cell mechanism. Moreover, while it is clear that 1 1 5 these strains of HCMV can differ in their ability to spread via cell-free progeny, whether they also differ in 1 1 6 their ability to spread cell-to-cell has not been addressed.
For quantitative comparisons of spread among HCMV strains, experiments similar to those described 1 1 8
for Figure 1 were performed, but instead of microscopy, flow cytometry was used to measure the increasing 1 1 9
number of infected (GFP-expressing) cells over the first 12 days of replication. In fibroblasts, the number of 1 2 0 infected cells for both TB and TR increased exponentially over 12 days, and fit well to a log-linear 1 2 1 regression, indicating a constant rate of spread over the course of the experiment (Fig 2A, B) . In contrast, 1 2 2 ME spread considerably faster between days 3 and 6, and then spread slower between days 9 and 12. The 1 2 3 average spread rates (LN GFP+ cells/day as indicated by the regression slopes in Fig. 2B ) of all three 1 2 4 strains were within 1.2-fold of each other, with only the difference between TB and TR reaching statistical 1 2 5 significance ( Fig. 2C ). This was somewhat unexpected, as ME has been described to replicate poorly 1 2 6 compared to other strains (38). Thus, the growth of the smaller, more tightly localized foci of ME were 1 2 7 characterized by initially rapid expansion followed by progressive slowing, whereas the more diffuse foci of 1 2 8 TB and TR were characterized by a constant rate of expansion. These results highlight how visual analyses 1 2 9
of focal size and pattern fail to detect the rapid, early focal expansion of ME. In epithelial cells, spread rates 1 3 0 for all three stains were lower than in fibroblasts, and there were greater differences between strains. ME 1 3 1 was approximately 2-fold faster than TR and 1.5 fold faster than TB, and all differences were statistically 1 3 2 significant ( Fig. 2D-F) . The more efficient spread by ME on epithelial cells was consistent with the higher 1 3 3 levels of gH/gL/UL128-131 as compared to TB and TR (38) (51) (27), but the tightly localized focal patterns 1 3 4
suggested inefficient cell-free spread by all three strains on this cell type.
3 5
Neutralizing antibodies were used to distinguish the contributions of cell-free and cell-to-cell 1 3 6 mechanisms to the rate of spread for each strain. Antibodies chosen for these experiments were mAb 14-1 3 7
4b, an anti-gH antibody that likely targets a discontinuous epitope at the membrane proximal region ( 5 2 , 1 3 8 5 3 )
, as well as a mixture of rabbit anti-peptide sera that target the epithelial tropism factors UL130 and 1 3 9
UL131
( 1 7 )
. The relative potency of these antibodies to neutralize cell-free TB, TR, and ME was verified in 1 4 0 neutralization experiments shown in Figure 3 . Note that on fibroblasts, 14-4b was approximately 10-fold 1 4 1 more potent against ME than for TB and TR, and there was a residual 20% of TR infectivity that was 1 4 2 resistant even at very high antibody concentrations ( Fig 3A) . On epithelial cells, potency of neutralization by 1 4 3
anti-UL130/131 antibodies was more similar among the strains, and complete neutralization of each was 1 4 4 achieved ( Fig. 3B ).
4 5
Spread rates of each strain in either fibroblast or epithelial cell cultures were then determined in the 1 4 6 presence or absence of anti-gH mAb 14-4b or anti-UL130/131 sera at concentrations sufficient for maximal 1 4 7 neutralization of cell-free virions. In fibroblast cultures, anti-gH 14-4b reduced the spread rate of TB and TR 1 4 8 by 70% and 55%, respectively, whereas ME spread was reduced by only 25% (Fig. 4 A-C). The apparent 1 4 9 resistance of ME spread was especially noteworthy since cell-free ME was more sensitive to neutralization 1 5 0 than either TB or TR (Fig. 3A) . In all cases, the apparent antibody resistant spread was greater than the 1 5 1 spread in the presence of ganciclovir, even for TR, which is known to harbor resistance mutations in the the infected cells and in the supernatants were then determined, and results shown in Figure 5 .
7 5
In fibroblasts, total intracellular viral genome accumulation was comparable for all three strains ( portion of these cytoplasmic and supernatant genomes would be expected to represent the infectious 1 8 0 progeny that could contribute to either cell-to-cell or cell-free spread, respectively. Despite the lower 1 8 1 numbers of progeny genomes for TB in cytoplasmic and supernatant fractions, these corresponded to log-1 8 2 folds greater cell-associated (i.e., sonically disrupted cells) and cell-free (i.e., supernatant) infectivity per cell 1 8 3 as compared to TR or ME (Fig. 5B ). The greater infectivity of TB, despite lower virion numbers was in 1 8 4 agreement with our previous measures of lower specific infectivity ratios (genome/PFU) for TB compared to 1 8 5 TR and ME (27) , and was positively correlated with the relative efficiencies of cell-free spread for these 1 8 6
strains. Surprisingly, cell-to-cell spread was inversely correlated to the levels of cell-associated infectivity, 1 8 7
with cell-to-cell spread of ME being highly efficient despite producing the lowest detectable cell-associated 1 8 8
infectivity.
8 9
In epithelial cells, accumulation of whole cell, cytoplasmic, and nuclear progeny genomes were 1 9 0 similar among all three strains (Fig. 5C ). In contrast, ME released nearly 10-fold more progeny genomes to 1 9 1 culture supernatants than did TB, and TR was by far the least efficient at releasing progeny to supernatants.
9 2
These results suggest major differences among strains in the later assembly and release stages of the 1 9 3 replication cycle in epithelial cells. As was observed in fibroblasts, ME had the lowest cell-associated 1 9 4 infectivity in epithelial cells, despite the more efficient cell-to-cell spread in this cell type ( Fig 5D and 4F ).
9 5
Infectivity in epithelial cell culture supernatants mirrored the quantities of genomes, indicating that the 1 9 6 epithelial-derived virions of all three strains are of comparable specific infectivity. This was in stark contrast 1 9 7
to the drastic differences in specific infectivity among these strains when produced in fibroblasts ( 
9 9
Taken together, these results confirmed that the robust cell-free spread of TB and TR in fibroblasts 2 0 0 was associated with the release of highly infectious progeny virus to the culture supernatant and that the 2 0 1 poor cell-free spread of ME was due to the low infectivity of the cell-free progeny. Surprisingly, ME was 2 0 2 much more efficient at cell-to-cell spread than TB despite having far less intracellular infectious progeny than 2 0 3 TB or TR. In epithelial cell cultures, the cell-free characteristics for all of the strains were more similar to one 2 0 4 another than they were on fibroblasts, and this was consistent with a comparably small contribution of cell-2 0 5 free spread for all three strains in this cell type. Thus, spread by all three strains in epithelial cells was 2 0 6
predominantly cell-to-cell, and ME was by far the most efficient whereas TR was notably inefficient. The 2 0 7
cell-to-cell spread of ME thus depends on efficient trafficking of progeny to adjacent cells, and this seems to 2 0 8 overcome the poor infectivity of the intracellular progeny.
0 9
The highly efficient cell-to-cell spread mechanism of HCMV ME is not determined by the high 2 1 0 expression of UL128-131. The cell-associated nature of ME has been linked to the high expression levels 2 1 1 of UL128-131 and the corollary poor infectivity of cell-free ME virions
. To address this in our 2 1 2 quantitative spread assay, we made use of the previously described tetracycline (Tet) repression system . Briefly, the BAC clone of ME used in these studies contained tetracycline-2 1 4 operator (TetO) sequences in the promoter of UL131. We previously showed that replication of this 2 1 5 recombinant ME in HFFFtet fibroblasts, which express the tetracycline-repressor (TetR) protein, produced 2 1 6 extracellular virus with dramatically reduced gH/gL/UL128-131, slightly higher gH/gL/gO and as a result, 2 1 7 greatly improved cell-free infectivity
In nHDF fibroblasts, MT spread slightly faster than ME, consistent with a gain in the ability to spread 2 3 4
cell-free as a result of the improved virion infectivity ( Fig 7A) . However, in the presence of neutralizing 2 3 5 antibody 14-4b, the spread of ME and MT was indistinguishable. Similar experiments were performed with 2 3 6
HFFFtet cells, which generate MT. The high-gH/gL/UL128-131 condition of ME was generated by addition 2 3 7 of doxycycline to the cultures to block the TetR repression of UL131 ( Fig 6A) . Spread rates were generally 2 3 8 lower in HFFFtet cells compared to nHDF cells, but as expected, MT spread more efficiently than ME, even 2 3 9
in the presence of neutralizing antibodies (Figs 7 A and B ). Thus, in both fibroblast systems, the efficiency 2 4 0 of ME cell-to-cell spread was not dependent on the high levels of gH/gL/UL128-131. Nor was the apparent 2 4 1 cell-to-cell spread a default mechanism of poor cell-free spread, and these results demonstrate a previously 2 4 2 unappreciated distinction of the mechanisms of cell-free and cell-to-cell spread.
4 3
In epithelial cells, repression of gH/gL/UL128-131 resulted in a decrease in average spread rate 2 4 4 (from 0.38 to 0.29), and small increase in the sensitivity of that spread to neutralizing anti-UL130/131 2 4 5 antibodies (from 10% to 30% inhibition) ( Fig 7B) . The reduction in spread rate was consistent with the 2 4 6 important role of gH/gL/UL128-131 for HCMV in these cells. One interpretation of the small increase in 2 4 7 antibody sensitivity was a shift towards increased cell-free spread. However, this seemed unlikely since 2 4 8 epithelial-derived MT were actually less infectious than epithelial-derived ME ( Fig 6C) . Thus, it seems more 2 4 9
likely that the observed spread of MT was still predominantly cell-to-cell, but that the reduced gH/gL/UL128-2 5 0 131 allowed for more efficient blocking of the cell-to-cell spread by these antibodies. It was notable that the 2 5 1 spread rates of MT in epithelial cells were comparable to those of TB both in the presence and absence of 2 5 2 neutralizing antibodies (compare Figs 4D and 7B ). This was consistent with the notion that both strains 2 5 3 spread in epithelial cells predominantly via cell-to-cell spread over the first 12 days. Thus, while the high-2 5 4 levels of gH/gL/UL128-131 of ME clearly enhance the efficiency of the spread in epithelial cells, this does not 2 5 5 appear to determine the mechanism, and these results suggest other intrastrain variable factors can affect 2 5 6
cell-to-cell spread in this cell type.
5 7
The RL13 glycoprotein tempers both cell-free and cell-to-cell spread. The RL13 ORF encodes 2 5 8
an envelope glycoprotein that has been described as a selective, or preferential inhibitor of cell-free spread 2 5 9
over cell-to-cell spread inasmuch as genotypes with inactivating mutations in RL13 arise during serial 2 6 0 propagation of HCMV in both fibroblasts and epithelial cells, and this has been correlated with the 2 6 1 appearance of more cell-free spread characteristics
. While the ME recombinant used in the 2 6 2 present studies harbors such an inactivating RL13 mutation, the RL13 expression status of the TB and TR 2 6 3 BAC-clones was unclear. DNA sequencing confirmed that the RL13 ORF of both TB and TR was intact 2 6 4 (data not shown), but lack of quality antibodies precluded confirmation of RL13 glycoprotein expression.
6 5
Thus, to directly and fairly compare the effects of RL13 on the spread of all three strains, and to avoid 2 6 6 potential selection of RL13 mutants in TB and TR during spread experiments, fibroblast and epithelial cell 2 6 7
lines that express RL13 were engineered. Immunoblot analysis demonstrated that these cell lines 2 6 8 expressed of both mature and immature proteoforms, and flow cytometry confirmed similar expression levels 2 6 9
( Fig 8) .
7 0
In fibroblasts, RL13 expression resulted in a comparable 40-50% reduction in spread rate for all three 2 7 1 strains ( Fig 9A) . The relative effect of neutralizing antibodies on spread by TB or TR was unaltered by RL13 2 7 2 expression, but spread of ME was 2-fold more sensitive to neutralizing antibodies in the RL13-expressing 2 7 3
fibroblasts. In epithelial cells, RL13 expression had no effect on the spread of TR but resulted in a modest 2 7 4 20% reduction for both TB and ME, although only for ME was this statistically reproducible ( Fig 9B) . Effects 2 7 5 of RL13 expression on antibody sensitivity were also different in epithelial cells than in fibroblasts. RL13 2 7 6 expression increased the sensitivity of TB spread to antibody inhibition, but had little effect on TR or ME ( Fig   2  7  7 9B). The notion that RL13 acts selectively or preferentially to restrict cell-free spread would have predicted 2 7 8 that a greater fraction of the observed spread in RL13-expressing cells would be cell-to-cell and therefore 2 7 9 less sensitive to neutralizing antibodies. On the contrary, results showed that sensitivity of spread to 2 8 0 neutralizing antibodies was either unaffected or enhanced in RL13-expressing cells compared to the control 2 8 1 cells. Thus, RL13 appears to exert its effect on HCMV spread in a manner that affects both the cell-free and 2 8 2 the cell-to-cell mechanisms, not preferentially cell-free spread. possibilities were tested using the RL13-expressing fibroblasts and epithelial cells. In fibroblasts, there were 2 8 8 modest reductions in the numbers of progeny released to culture supernatants for TB and ME ( Fig 10A) .
8 9
There were also modest reductions in detectable infectivity in culture supernatants of the RL-13 expressing 2 9 0 cells ( Fig 10B. ) Taken together, the correlation between reduced numbers and reduced infectivity suggest 2 9 1 that the specific infectivity of cell-free virions was not substantially affected by RL13-expression. For the 2 9 2 efficient cell-free spreaders TB and TR, these reductions in cell-free progeny quantity and/or infectivity may 2 9 3 help explain the reductions in spread rates described above. In contrast, the reduction of cell-to-cell spread 2 9 4
for ME could not be attributed to reduced cell-free progeny quantity or infectivity.
9 5
In epithelial cells, there were no effects on the numbers of supernatant progeny released for TB or 2 9 6 TR, but there were actually more cell-free ME progeny produced from RL13-expressing cells (Fig. 10C ).
9 7
Despite the greater numbers of ME progeny in RL13-expressing epithelial cell supernatants, there were 2 9 8 drastically lower levels of infectivity, indicating a substantial reduction in the per virion infectivity (Fig. 10D ).
9 9
However, as was noted above for fibroblasts, since the spread of ME in epithelial cells was determined to be 3 0 0
predominately cell-to-cell, these effects on cell-free virus may not fully explain how RL13 tempers spread in 3 0 1 this cell type.
0 2
The drastic reduction of ME cell-free infectivity due to RL13 expression in epithelial cells suggested 3 0 3 effects on the envelope glycoproteins. In particular, gH/gL/UL128-131 is the only envelope glycoprotein 3 0 4 currently known to be specifically required for efficient infection of epithelial cells. Thus, ME virions produced 3 0 5 by RL13-expressing or control fibroblasts and epithelial cells were analyzed by immunoblot for the levels of 3 0 6 gH/gL complexes. Consistent with our previous reports ( Fig. 6B, and (51) ), ME virions produced by 3 0 7
fibroblasts had gH/gL predominately in the form of gH/gL/UL128-131 ( Fig 11A) . Strikingly, epithelial-derived 3 0 8 ME contained substantially greater amounts of gH/gL/UL128-131 than fibroblast-derived ME (Fig 11A) . In . In fibroblasts, ME virions contained almost entirely furin-cleaved gB, as evidenced by 3 1 4 detection of only a 55kDa band ( Fig 11B) . This was not affected by RL13-expression. In contrast, epithelial-3 1 5
derived ME contained mostly uncleaved gB, and RL13-expression drastically reduced the amount of this 3 1 6 proteoform ( Fig 11B) . Together, these results indicated that RL13 can affect the processing and 3 1 7
incorporation of gH/gL complexes and gB into cell-free progeny, albeit in a cell type-dependent manner . 
. This variation fits well with the growing evidence of genotypic passage clinical isolates spread more rapidly than others ( 6 1 )
. They interpreted slow kinetics to represent a 3 3 5
cell-associated-only phenotype and fast kinetics to represent a phenotype of both cell-associated and cell-3 3 6 free spread. Indeed, the faster spreading isolates were more sensitive to the presence of neutralizing 3 3 7
antibodies. Together, these and other studies suggest considerable variation in the modes of spread 3 3 8
exhibited by genetically distinct HCMV, but the exact genetic variations that determine these phenotypes 3 3 9 remain unclear.
4 0
Here we applied a flow cytometry-based approach to compare the spread characteristics of . The results presented here demonstrate that the cell-associated characteristic of ME is not simply due 3 5 4
to the poor cell-free infectivity. Rather, ME is capable of a specifically efficient cell-to-cell mechanism of 3 5 5 spread, TB is specifically inefficient at cell-to-cell spread, and TR may be of intermediate cell-to-cell spread 3 5 6
capacity. Moreover, we demonstrate that cell-free and cell-associated spread characteristics are not 3 5 7
determined by either the expression levels of UL128-131 or by RL13 expression, although these loci do 3 5 8
influence the efficiency in strain-dependent and cell type-dependent manners. Thus, we suggest the 3 5 9
involvement of other variable loci in distinct mechanisms of cell-free and cell-to-cell spread, and that in 3 6 0 epistatic relationships among these loci govern the efficiency of these processes.
6 1
One candidate for a variable factor that might influence cell-free and cell-to-cell spread in an epistatic 3 6 2 manner is gO, which is one of the more diverse proteins encoded by HCMV. backgrounds could influence the efficiency of cell-to-cell spread, demonstrating that there were epistatic 3 7 1 phenomena involved inasmuch as the influence of some UL74 alleles were observed in only one of the two 3 7 2 genetic backgrounds (66).
7 3
Our finding that the level of gH/gL/UL128-131 expression did not affect the spread rate of ME in 3 7 4
fibroblasts conflicts with a report by Stanton et al., which showed UL128-null ME plaques significantly larger 3 7 5 than UL128-intact ME plaques ( 4 0 )
. The apparent contradiction may be explained by the fact that our flow 3 7 6 cytometry assays measured spread rates averaged over the first 12 days, as compared to the 3 7 7 measurements of 21-day plaque sizes by Stanton et al. Linear regression analyses of the data collected by 3 7 8 flow cytometry indicated that ME spread at a faster rate between days 3 and 6, and then began to slow after 3 7 9 day 9, whereas the constant rate of cell-free spread demonstrated by TB and TR (Fig. 2) . The slowdown 3 8 0 displayed by ME may simply reflect a limiting number of potential uninfected target cells available via cell-to-3 8 1 cell spread during focal expansion. Alternatively, it could be that the cells at the periphery of an expanding 3 8 2 ME foci rapidly become less permissive, for example via activation of the antiviral state. In any case, the 3 8 3 increase in 21 day plaque size of a UL128-null ME is consistent with enhanced cell-free infectivity, but our 3 8 4 analysis of spread rates over 12 days indicates this does not come at the expense of a distinct and 3 8 5
comparably efficient mode of cell-to-cell spread. This interpretation is supported by the observation that the 3 8 6
12 day spread rate of ME was highly resistant to neutralizing antibodies regardless of gH/gL/UL128-131 3 8 7 expression level ( Fig. 7) and is consistent with Laib Sampaio et al., who showed much greater cell-free 3 8 8 dispersion of UL128-null ME foci, but more similar antibody resistant, cell-associated spread with or without 3 8 9
UL128
( 2 4 )
.
9 0
In epithelial cells, repression of gH/gL/UL128-131 did reduce the 12 day spread rate for ME (Fig 7) .
9 1
This was consistent with reduced plaques sizes of UL128-null ME documented by Murrell et al., and likely 3 9 2 reflects the important role of gH/gL/UL128-UL131 in epithelial cells (  3  8  ) . However, as observed in 3 9 3 fibroblasts, spread in epithelial cells was still highly resistant to neutralizing antibodies when gH/gL/UL128-3 9 4 131 was repressed. This was different than Murrell et al., who concluded that spread of ME in epithelial cells 3 9 5
was more sensitive to antibodies when gH/gL/UL128-131 was reduced ( 4 2 )
. Again the discrepancy may 3 9 6
indicate that analyses of 21-day plaque size likely accentuate the influence of cell-free infectivity and masks 3 9 7
the contribution of cell-to-cell spread. Thus, by measuring average spread rates over 12 days, we find that 3 9 8 gH/gL/UL128-131 levels are not the sole determinate of the cell-free versus cell-associated spread 3 9 9 phenotype for ME. Rather, the increase in cell-free infectivity due to reduction in gH/gL/UL128-131 and the 4 0 0 concomitant increase in gH/gL/gO, is independent of the highly efficient cell-to-cell mode of spread.
0 1
The RL13 glycoprotein was another candidate for a factor influencing the cell-free and cell- . On the contrary, we find that RL13 tempers HCMV spread by either cell-free or cell-to-cell 4 0 5 mechanisms and that this temperance was more pronounced in fibroblasts compared to epithelial cells ( Fig.   4 0 6 9). Interestingly, RL13 expression dramatically reduced the infectivity of cell-free virions released by ME 4 0 7 from epithelial cells, and this was consistent with the previous report showing low cell-free titers for RL13-4 0 8
intact ME in epithelial cell cultures compared to RL13 mutant ME ( 4 0 )
. The physiological basis of this 4 0 9 infectivity loss remains unclear, but it correlated with the observations that ME virions produced in RL13-4 1 0 expressing epithelial cells contained less full length, non-furin cleaved gB (Fig. 11) it may be that both strains carry mutations or polymorphisms in promoter or other regulatory sequences that 4 2 6 impact RL13 expression. Moreover, our results suggest that the selection against RL13 may be more 4 2 7 extensive in fibroblasts but less pronounced in epithelial cells.
2 8
Notably, a recent report showed that the presence of neutralizing antibodies during subculturing of . If these clinical isolates were similar to ME in their proclivity for cell-to-cell spread, it would 4 3 1 seem logical that neutralizing antibodies would reduce the selective advantage of cell-free infectivity 4 3 2 conferred by UL128-131 mutation. Indeed, it is interesting that ME was also isolated from a clinical urine 4 3 3 sample ( 1 0 )
. However, the preservation of RL13 seems less intuitive since RL13 impacts both cell-free and 4 3 4
cell-to-cell modes of spread. Given the variable effects we observed of RL13 on different strains, these 4 3 5
observations again seem to point to epistasis phenomena, where the relative effect of any given perturbation 4 3 6
at one variable locus is influenced by variable physiology related to other polymorphic loci.
3 7
Our data also shed new light on the notion that the cell type might influence phenotypic properties in . This is in stark contrast to our results that epithelial-derived HCMV contained greater 4 4 4 amounts of gH/gL/UL128-131 than fibroblast-derived virus (Fig 9) . There are several possible, non-mutually 4 4 5 exclusive explanations for this discrepancy. This could reflect differences between strains as the prior study 4 4 6 used TB, whereas our analyses used ME. There could also be differences between endothelial and 4 4 7 epithelial cells. Finally, the Scrivano et al. analysis normalized virion immunoblots to gB, whereas we used 4 4 8 major capsid protein (MCP). It is possible that incorporation of gB into progeny virus is affected by 4 4 9
glycoprotein processing/secretory pathway differences between cell type, whereas plasticity in the number of 4 5 0 subunits per capsid subunits seems less likely. Indeed, we observed differences in the proteolytic 4 5 1 processing and virion incorporation of gB when ME was produced in fibroblast and epithelial cells.
5 2
In conclusion, we have characterized very different cell-free and cell-associated spread phenotypes 4 5 3 among three commonly studied BAC clones of HCMV. Our data suggest that these phenotypic variances 4 5 4
are manifest through the combined influenced of diversity at multiple genetic loci other than UL128-131 and 4 5 5
RL13. How this phenotypic variation is represented in vivo remains unclear. There is little clear evidence to 4 5 6 support the notion that HCMV is predominately cell-associated in vivo. The endemic nature, and the 4 5 7
pleomorphic disseminated disease presentations suggest that HCMV is able to thrive in many different 4 5 8
bodily environments as it spreads within and among individual human hosts. Copious amounts of cell-free 4 5 9
virus are shed in urine, saliva, and breast milk, and this is likely a major route of transmission between 4 6 0 individuals, whereas HCMV in the blood is likely highly associated with leukocytes ( 7 0 -7 2 )
. Thus, it seems 4 6 1 likely that both cell-free and cell-associated modes of spread are important to the natural history of HCMV. . BAC clone Merlin (ME)(pAL1393), which contains tetracycline operator sequences within the ( 1 7 )
1 0
Vrial spread assays. Approx. 1x10 5 (3x10 5 ) nHDFs (ARPEs) were seeded into 6-well culture plates and 5 1 1 allowed to grow to confluence. Confluent monolayers of nHDFs or ARPE cells were inoculated with 100-5 1 2
1000 IUs of strains TB, TR, or ME at for 4hrs at 37°C. Cells were then washed extensively with PBS and used to identify GFP+ cells, and only cells with median GFP intensities 10-fold above background were 5 2 6 considered positive. RL13 expression was measured using an intracellular staining kit (Thermo) and an anti-5 2 7
6x His antibody conjugated to AlexaFluor-647 (Thermo) using the RL-2 laser (647nm).
2 8
qPCR. The real-time quantitative PCR (qPCR) assay used to quantify viral or cellular DNA molecules was 5 2 9
performed as previously described (  2  7  ) . Briefly, HCMV DNA inside cell-free particles was purified using the 5 3 0
PureLink Viral RNA/DNA mini kit (Thermo Scientific). A region within UL83 conserved among ME, TR, and 5 3 1 TB was chosen as the HCMV-specific amplicon, and viral genomes were quantified by SYBR green qPCR 5 3 2 as previously described. Standard curves were performed using serial dilutions of a single PCR DNA band cells. Confluent 9.5cm 3 monolayers of fibroblasts or epithelial cells were infected at MOI 0.001 with GFP-8 3 5
expressing HCMV strains TB, TR, or ME and allowed to spread in the presence of either anti-gH mAb 14-4b 8 3 6 (A-C), anti-UL130/131 rabbit sera (D-F), or ganciclovir (all panels). The average spread rates over 12 days 8 3 7
(LN GFP+ cells per day; as in Fig 2) for TB, TR, and ME on fibroblasts (A-C) and epithelial cells (D-F) are 8 3 8
shown. Conditions where no spread was detected are designated "n.d.". All experiments were performed 8 3 9 three times and error bars represent standard deviation. P-values were generated by unpaired, two-tailed t-8 4 0 test vs. mock (*<0.05, **<0.01, ***<0.001). 
